{"abstract": "Amgen will pay $425 million and perhaps $575 million in milestone payments to BioVex, a maker of experimental cancer drugs.", "web_url": "https://www.nytimes.com/2011/01/25/business/25amgen.html", "snippet": "Amgen will pay $425 million and perhaps $575 million in milestone payments to BioVex, a maker of experimental cancer drugs.", "lead_paragraph": "Amgen said it agreed to buy BioVex, a closely held maker of experimental cancer drugs, for $425 million and as much as $575 million in milestone payments.", "print_section": "B", "print_page": "9", "source": "The New York Times", "multimedia": [], "headline": {"main": "Amgen Buys a Cancer Drug Maker", "kicker": null, "content_kicker": null, "print_headline": "Amgen Buys a Cancer Drug Maker", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 1, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "subject", "value": "Cancer", "rank": 3, "major": "N"}, {"name": "organizations", "value": "AMGEN INC", "rank": 4, "major": "N"}], "pub_date": "2011-01-25T04:05:22+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Bloomberg News", "person": [{"firstname": "Bloomberg", "middlename": null, "lastname": "News", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/e50b70c5-7f68-5ee0-afe4-14b165c85583", "word_count": 165, "uri": "nyt://article/e50b70c5-7f68-5ee0-afe4-14b165c85583"}